Overexpression of ErbB2 affects the actin cytoskeleton, and thus plays a role in the metastatic progression in cancer cells (Brix et al., 2014; Day et al., 2017), which resembles the major cause of mortality (Dillekas et al., 2019). The gene discussed is ERBB2; the disease is cancer.